Champions Oncology (CSBR) Prepaid Assets (2011 - 2026)
Champions Oncology (CSBR) recorded quarterly Prepaid Assets of $991000.0 in Q1 2026, down 22.4% quarter-over-quarter from $1.3 million in Q4 2025, and up 38.99% on a YoY basis from $713000.0 in Q1 2025.
Champions Oncology (CSBR) Prepaid Assets (2011 - 2026) Analysis & Trends
Champions Oncology's Prepaid Assets history runs 16 years deep, the most recent figure standing at $991000.0 for Q1 2026.
- In Q1 2026, Prepaid Assets rose 38.99% year-over-year to $991000.0; the TTM figure through Jan 2026 stood at $991000.0 (up 38.99% YoY), while the FY2025 annual figure was $1.4 million, down 8.43% from the prior year.
- Prepaid Assets was $991000.0 for Q1 2026 at Champions Oncology, down from $1.3 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.5 million in Q2 2024 to a low of $561000.0 in Q1 2022.
- Historically, Prepaid Assets has averaged $1.0 million across 5 years, with a median of $991000.0 in 2026.
- Biggest YoY gain for Prepaid Assets was 48.49% in 2025; the steepest drop was 14.61% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $834000.0 in 2022, then retreated by 6.47% to $780000.0 in 2023, then advanced by 10.26% to $860000.0 in 2024, then jumped by 48.49% to $1.3 million in 2025, then fell by 22.4% to $991000.0 in 2026.
- The last three Prepaid Assets figures came in at $991000.0 (Q1 2026), $1.3 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Champions Oncology | 78.46 Mn | 71.46 Mn | 13.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 991,000.00 |
| Oct 31, 2025 | 1.28 Mn |
| Jul 31, 2025 | 1.22 Mn |
| Apr 30, 2025 | 1.37 Mn |
| Jan 31, 2025 | 713,000.00 |
| Oct 31, 2024 | 860,000.00 |
| Jul 31, 2024 | 1.25 Mn |
| Apr 30, 2024 | 1.50 Mn |
| Jan 31, 2024 | 835,000.00 |
| Oct 31, 2023 | 780,000.00 |
| Jul 31, 2023 | 1.11 Mn |
| Apr 30, 2023 | 1.33 Mn |
| Jan 31, 2023 | 661,000.00 |
| Oct 31, 2022 | 834,000.00 |
| Jul 31, 2022 | 958,000.00 |
| Apr 30, 2022 | 1.14 Mn |
| Jan 31, 2022 | 561,000.00 |
| Oct 31, 2021 | 731,000.00 |
| Jul 31, 2021 | 864,000.00 |
| Apr 30, 2021 | 957,000.00 |